Asthma Study

In Uncategorized on March 12, 2010 at 7:42 pm

Efficacy, Short Term Safety and Serum Bio Markers In a Clinical Trial of IND#70190

The study shows the efficacy of IND#70190, as well as warrants identification and characterizations of biomarkers for asthma, which is essential for early diagnosis and more effective treatment.  Asthma affects 300 million people worldwide as of 2009.  The use of IND#70190 would likely have a significant impact on those dealing with asthma.  

Dr. Sung Baek and fellow researchers from The Institute of Drug Development had analyzed a natural product blend, known as IND#70190 during the study, on asthma sufferers.  In studying the short-term safety and efficacy of the natural product, it was found to have no adverse effects.  It was also found that significant inhibition of Matrix Metalloproteinase-9 (MMP-9) correlated with increased airflow.  STUDY DETAILS

Researchers: Dr. Sung Baek, Dr. David Campos, Dr. Armando Diaz, Dr. John Cornell, and Dr. Elzbieta Izbicka

Posted via web from Mind and Body Health Myths that You Still Believe – Bioprin

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: